Nucleic acid tests for clinical translation

M Li, F Yin, L Song, X Mao, F Li, C Fan, X Zuo… - Chemical …, 2021 - ACS Publications
Nucleic acids, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), are
natural biopolymers composed of nucleotides that store, transmit, and express genetic …

[HTML][HTML] The role of Nrf2 in liver disease: novel molecular mechanisms and therapeutic approaches

D Xu, M Xu, S Jeong, Y Qian, H Wu, Q Xia… - Frontiers in …, 2019 - frontiersin.org
Oxidative stress and inflammation are the most important pathogenic events in the
development and progression of liver diseases. Nuclear erythroid 2-related factor 2 (Nrf2) is …

[HTML][HTML] Epitranscriptomics in liver disease: basic concepts and therapeutic potential

Z Zhao, J Meng, R Su, J Zhang, J Chen, X Ma… - Journal of hepatology, 2020 - Elsevier
The development of next-generation sequencing technology and the discovery of specific
antibodies targeting chemically modified nucleotides have paved the way for a new era of …

Pooled CRISPR screening identifies m6A as a positive regulator of macrophage activation

J Tong, X Wang, Y Liu, X Ren, A Wang, Z Chen… - Science …, 2021 - science.org
m6A RNA modification is implicated in multiple cellular responses. However, its function in
the innate immune cells is poorly understood. Here, we identified major m6A “writers” as the …

Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats

J Wang, J Shen, Q Gao, Z Ye, S Yang, H Liang… - Stroke, 2008 - Am Heart Assoc
Background and Purpose—Ischemic postconditioning has been found to decrease brain
infarct area and spinal cord ischemic injury. In this study, we tested the hypothesis that …

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open …

S Qin, M Chen, AL Cheng, AO Kaseb, M Kudo, HC Lee… - The Lancet, 2023 - thelancet.com
Background No adjuvant treatment has been established for patients who remain at high
risk for hepatocellular carcinoma recurrence after curative-intent resection or ablation. We …

[PDF][PDF] Cbx4 governs HIF-1α to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity

J Li, Y Xu, XD Long, W Wang, HK Jiao, Z Mei, QQ Yin… - Cancer cell, 2014 - cell.com
Cbx4 is a polycomb group protein that is also a SUMO E3 ligase, but its potential roles in
tumorigenesis remain to be explored. Here, we report that Cbx4, but not other members of …

[HTML][HTML] YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

J Hou, H Zhang, J Liu, Z Zhao, J Wang, Z Lu, B Hu… - Molecular cancer, 2019 - Springer
Background Dynamic N 6-methyladenosine (m 6 A) modification was previously identified
as a ubiquitous post-transcriptional regulation that affected mRNA homeostasis. However …

Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell

N Xu, J Zhang, C Shen, Y Luo, L Xia, F Xue… - … and biophysical research …, 2012 - Elsevier
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Systemic
chemotherapy plays an important role in the treatment of patients with advanced liver …

[HTML][HTML] Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma

J Hou, Y Zhou, Y Zheng, J Fan, W Zhou, IOL Ng, H Sun… - Cancer cell, 2014 - cell.com
In hepatocellular carcinoma (HCC), biomarkers for prediction of prognosis and response to
immunotherapy such as interferon-α (IFN-α) would be very useful in the clinic. We found that …